IN188837B - - Google Patents

Info

Publication number
IN188837B
IN188837B IN935CA1998A IN188837B IN 188837 B IN188837 B IN 188837B IN 935CA1998 A IN935CA1998 A IN 935CA1998A IN 188837 B IN188837 B IN 188837B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Alangudi Sankaranarayanan
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Priority to IN935CA1998 priority Critical patent/IN188837B/en
Priority to RU2000132204/04A priority patent/RU2222532C2/ru
Priority to JP2000550478A priority patent/JP2002516275A/ja
Priority to CA002333001A priority patent/CA2333001A1/en
Priority to HU0101584A priority patent/HUP0101584A3/hu
Priority to AU36232/99A priority patent/AU3623299A/en
Priority to BR9910628-0A priority patent/BR9910628A/pt
Priority to PCT/IB1999/000892 priority patent/WO1999061430A1/en
Priority to CA002332950A priority patent/CA2332950A1/en
Priority to DE69918431T priority patent/DE69918431T2/de
Priority to AT99918219T priority patent/ATE270279T1/de
Priority to EP99918219A priority patent/EP1080081B1/en
Priority to AU36233/99A priority patent/AU3623399A/en
Priority to HU0102057A priority patent/HUP0102057A3/hu
Priority to CN99806440A priority patent/CN1302205A/zh
Priority to ES99918219T priority patent/ES2222029T3/es
Priority to PT99918219T priority patent/PT1080081E/pt
Priority to AT99918220T priority patent/ATE245419T1/de
Priority to CZ20004072A priority patent/CZ20004072A3/cs
Priority to JP2000550836A priority patent/JP3378239B2/ja
Priority to CN99806421A priority patent/CN1301258A/zh
Priority to RU2000132206/14A priority patent/RU2209065C2/ru
Priority to DE69909782T priority patent/DE69909782D1/de
Priority to EP99918220A priority patent/EP1079829B1/en
Priority to BR9910637-0A priority patent/BR9910637A/pt
Priority to PCT/IB1999/000893 priority patent/WO1999061018A1/en
Priority to US09/565,917 priority patent/US6248895B1/en
Priority to US09/690,805 priority patent/US6232331B1/en
Publication of IN188837B publication Critical patent/IN188837B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN935CA1998 1998-05-22 1998-05-22 IN188837B (da)

Priority Applications (28)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (da) 1998-05-22 1998-05-22
RU2000132204/04A RU2222532C2 (ru) 1998-05-22 1999-05-17 Соединения ряда бензофуроксана, способ их получения (варианты), фармацевтическая композиция, способ получения парентерального состава и способ лечения коронарных сердечных заболеваний
JP2000550478A JP2002516275A (ja) 1998-05-22 1999-05-17 狭心症治療におけるベンゾフロキサン誘導体の使用
CA002333001A CA2333001A1 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris
HU0101584A HUP0101584A3 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris
AU36232/99A AU3623299A (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris
BR9910628-0A BR9910628A (pt) 1998-05-22 1999-05-17 Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária
PCT/IB1999/000892 WO1999061430A1 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris
CA002332950A CA2332950A1 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
DE69918431T DE69918431T2 (de) 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
AT99918219T ATE270279T1 (de) 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
EP99918219A EP1080081B1 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris
AU36233/99A AU3623399A (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
HU0102057A HUP0102057A3 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
CN99806440A CN1302205A (zh) 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物在治疗心绞痛中的应用
ES99918219T ES2222029T3 (es) 1998-05-22 1999-05-17 Derivados de benzofuroxano y su uso en el tratamiento de angina de pecho.
PT99918219T PT1080081E (pt) 1998-05-22 1999-05-17 Derivados do benzofuraxano e a sua utilizacao no tratamento da angina de peito
AT99918220T ATE245419T1 (de) 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
CZ20004072A CZ20004072A3 (cs) 1998-05-22 1999-05-17 Farmaceutické přípravky pro léčení kardiovaskulárních poruch
JP2000550836A JP3378239B2 (ja) 1998-05-22 1999-05-17 ベンゾフロキサン誘導体及びそれを含有する心臓血管性疾患治療剤
CN99806421A CN1301258A (zh) 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用
RU2000132206/14A RU2209065C2 (ru) 1998-05-22 1999-05-17 Применение производных бензофуроксана при лечении стенокардии
DE69909782T DE69909782D1 (de) 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
EP99918220A EP1079829B1 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
BR9910637-0A BR9910637A (pt) 1998-05-22 1999-05-17 Composto da série da benzofuroxana usada para distúrbios cardiovasculares, processos para a preparação dos derivados de benzofuroxana, e para a preparação de 5 (6)-[(2,3-diidróxi propilóxi)-carbonil] benzofuroxana, uso do composto, composição farmacêutica, processo para a preparação da mesma, e, processo para o tratamento de um mamìfero, incluindo um ser humano, de doença cardìacas da coronária.
PCT/IB1999/000893 WO1999061018A1 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
US09/565,917 US6248895B1 (en) 1998-05-22 2000-05-05 Benzofuroxan compound, method of preparation, pharmaceutical composition and method of treatment using the same
US09/690,805 US6232331B1 (en) 1998-05-22 2000-10-18 Benzofuroxan derivatives, their therapeutic uses and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (da) 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
IN188837B true IN188837B (da) 2002-11-09

Family

ID=11085434

Family Applications (1)

Application Number Title Priority Date Filing Date
IN935CA1998 IN188837B (da) 1998-05-22 1998-05-22

Country Status (16)

Country Link
US (2) US6248895B1 (da)
EP (2) EP1080081B1 (da)
JP (2) JP2002516275A (da)
CN (2) CN1301258A (da)
AT (2) ATE270279T1 (da)
AU (2) AU3623299A (da)
BR (2) BR9910628A (da)
CA (2) CA2333001A1 (da)
CZ (1) CZ20004072A3 (da)
DE (2) DE69918431T2 (da)
ES (1) ES2222029T3 (da)
HU (2) HUP0102057A3 (da)
IN (1) IN188837B (da)
PT (1) PT1080081E (da)
RU (2) RU2222532C2 (da)
WO (2) WO1999061018A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
WO2004050084A2 (en) * 2002-11-29 2004-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and nitricoxid-donor activity
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
AU2009266408C1 (en) * 2008-07-02 2015-12-10 The University Of Queensland Pain-relieving compositions of furoxan NO donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions
CN104592145B (zh) * 2015-01-15 2017-05-17 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Also Published As

Publication number Publication date
CA2332950A1 (en) 1999-12-02
DE69909782D1 (de) 2003-08-28
WO1999061430A1 (en) 1999-12-02
AU3623399A (en) 1999-12-13
ATE245419T1 (de) 2003-08-15
BR9910637A (pt) 2001-02-06
HUP0102057A2 (hu) 2001-11-28
JP2002516275A (ja) 2002-06-04
US6248895B1 (en) 2001-06-19
PT1080081E (pt) 2004-10-29
DE69918431T2 (de) 2005-07-14
CN1302205A (zh) 2001-07-04
JP3378239B2 (ja) 2003-02-17
RU2209065C2 (ru) 2003-07-27
EP1079829A1 (en) 2001-03-07
HUP0102057A3 (en) 2002-12-28
US6232331B1 (en) 2001-05-15
DE69918431D1 (de) 2004-08-05
EP1079829B1 (en) 2003-07-23
CN1301258A (zh) 2001-06-27
ATE270279T1 (de) 2004-07-15
HUP0101584A3 (en) 2002-12-28
RU2222532C2 (ru) 2004-01-27
WO1999061018A1 (en) 1999-12-02
JP2002516317A (ja) 2002-06-04
CZ20004072A3 (cs) 2001-08-15
CA2333001A1 (en) 1999-12-02
EP1080081A1 (en) 2001-03-07
EP1080081B1 (en) 2004-06-30
AU3623299A (en) 1999-12-13
BR9910628A (pt) 2001-01-30
ES2222029T3 (es) 2005-01-16
HUP0101584A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
BE2014C048I2 (da)
JP2003524532A5 (da)
JP2001526127A5 (da)
BRPI9917862A2 (da)
JP2001514436A5 (da)
BRPI9914151B8 (da)
BE2011C024I2 (da)
JP2001527339A5 (da)
IN188837B (da)
DK199800393U4 (da)
JP2000158515A5 (da)
BRPI9917863A2 (da)
KR100474443B1 (da)
IN189013B (da)
IN2001MU00063A (da)
JP2584866C (da)
JP2586126C (da)
JP2504734C (da)
JP2598720C (da)
JP2597540C (da)
IN192477B (da)
CN3082609S (da)
CN3081515S (da)
CN3079461S (da)
BY6371C1 (da)